TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36473763

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 30
Study: 32865344

Group type: EXPERIMENTAL
Intervention: Multicolumn spinal cord stimulation (SCS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Monocolumn spinal cord stimulation (SCS)
Number of subjects: 115
Study: 32960643

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (21 g over a week, 7 g per day on Monday, Wednesday, and Friday)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo drink (control group)
Number of subjects: 12
Study: 35045394

Group type: EXPERIMENTAL
Intervention: Shallow trochlear geometry with medialization of tibial tubercle
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Deep trochlear geometry with medialization of tibial tubercle
Number of subjects: 750
Study: 34616836

Group type: EXPERIMENTAL
Intervention: CXCR2 antagonism with danirixin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 43
Study: 33012654

Group type: EXPERIMENTAL
Intervention: Migalastat 150 mg every other day (QOD)
Number of subjects: 46
Study: 34384301

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 50 U
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 25 U
Number of subjects: 61

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study: 32539786

Group type: EXPERIMENTAL
Intervention: Oral non-absorbable antibiotic prophylaxis (OAP) with tobramycin and colistin for three days preoperatively
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 35723850

Group type: EXPERIMENTAL
Intervention: Thymus kotschyanus extract (0.5 g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33783517

Group type: EXPERIMENTAL
Intervention: Breath test using HPPI-TOFMS
Number of subjects: 428
Study: 34086513

Group type: EXPERIMENTAL
Intervention: Community-based exercise program for persons with MS
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Other gym participation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Home training
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: No specific program
Number of subjects: 56
Study: 32623088

Group type: EXPERIMENTAL
Intervention: NETOIMS
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 36259579

Group type: EXPERIMENTAL
Intervention: Integrated multidomain intervention (16 sessions of 2 hours each, including physical exercise, cognitive training, dietician education, and individualized integrated care)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Integrated multidomain intervention
Number of subjects: 340
Study: 33185585

Group type: EXPERIMENTAL
Intervention: Risk factor education (checklists of risk factors and handbooks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Risk factor education
Number of subjects: 46
Study: 35553446

Group type: EXPERIMENTAL
Intervention: TRF with whey protein supplementation (25 g/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control, TRF
Number of subjects: 16
Study: 33909554

Group type: EXPERIMENTAL
Intervention: Cetirizine 1%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Minoxidil 5%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Cetirizine 1% and Minoxidil 5%)
Number of subjects: 40
Study: 32592082

Group type: EXPERIMENTAL
Intervention: Ridaforolimus eluting EluNIR stent
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group from BIONICS trial
Number of subjects: 104
Study: 35026217

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over Broca's area
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over Broca's area
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 160
Study: 34061178

Group type: EXPERIMENTAL
Intervention: Left-sided metastatic colorectal cancer patients (n=6856)
Number of subjects: 9277

Group type: EXPERIMENTAL
Intervention: Left-sided KRAS wild-type tumors
Number of subjects: 9277

Group type: EXPERIMENTAL
Intervention: Left-sided KRAS wild-type tumors receiving anti-EGFR treatment
Number of subjects: 9277

Group type: COMPARATOR
Intervention: Right-sided metastatic colorectal cancer patients (n=2421)
Number of subjects: 9277
Study: 35482567

Group type: EXPERIMENTAL
Intervention: High dose dexmedetomidine (0.04 mg/kg, IM) + midazolam (3 mg/kg, IM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low dose dexmedetomidine (0.01 mg/kg, IM) + midazolam (3 mg/kg, IM)
Number of subjects: 20
Study: 32657946

Group type: EXPERIMENTAL
Intervention: Reltecimod (0.5 mg/kg)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 36496349

Group type: EXPERIMENTAL
Intervention: DWP16001 2 mg with gemigliptin (50 mg once-daily) and metformin (1000 mg twice-daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: DWP16001 2 mg without gemigliptin and metformin
Number of subjects: 34
Study: 32618438

Group type: EXPERIMENTAL
Intervention: Marketed 150 mg peficitinib tablet under fasted conditions
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Marketed 150 mg peficitinib tablet under fed conditions
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Marketed 150 mg peficitinib tablet
Number of subjects: 58
Study: 32250337

Group type: EXPERIMENTAL
Intervention: EMG-triggered FES during PNF trunk pattern
Number of subjects: 40

Group type: COMPARATOR
Intervention: PNF trunk pattern
Number of subjects: 40
Study: 34749425

Group type: EXPERIMENTAL
Intervention: Intensive olfactory training (IOT) - twice a day with a 40-odor set for 15 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conservative management (Control)
Number of subjects: 65
Study: 33497874

Group type: EXPERIMENTAL
Intervention: Mindfulness awareness program (MAP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Active control condition (health education program)
Number of subjects: 54
Study: 33116470

Group type: EXPERIMENTAL
Intervention: Systemic steroid therapy administered to 658 patients (53%)
Number of subjects: 1237

Group type: COMPARATOR
Intervention: Non-steroid users
Number of subjects: 1237
Study: 35536726

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with 30 pulses per minute
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with 70 pulses per minute
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-pulsatile perfusion
Number of subjects: 90
Study: 34236951

Group type: EXPERIMENTAL
Intervention: Traffic safety education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition of an occupational therapy driving intervention
Number of subjects: 0
Study: 32849284

Group type: EXPERIMENTAL
Intervention: Nutraceutical containing Bergamot polyphenol fraction and Cynara Cardunculus extract, 300 mg/day for 12 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Nutraceutical
Number of subjects: 102
Study: 35622972

Group type: COMPARATOR
Intervention: Pacritinib (PAC) 400 mg daily in PERSIST-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pacritinib (PAC) 400 mg daily or 200 mg twice daily in PERSIST-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC) 200 mg twice daily in PAC203 study
Number of subjects: 0
Study: 32270865

Group type: EXPERIMENTAL
Intervention: Group electronic monitoring of hand hygiene
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (baseline measurement)
Number of subjects: 26
Study: 34979178

Group type: EXPERIMENTAL
Intervention: Daily steps (average 3,460 ± 1,768 steps per day)
Number of subjects: 66
Study: 36344987

Group type: EXPERIMENTAL
Intervention: Oral doxycycline
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 36296964

Group type: EXPERIMENTAL
Intervention: INTAKE24©
Number of subjects: 55

Group type: COMPARATOR
Intervention: ASA24®
Number of subjects: 55
Study: 33377242

Group type: EXPERIMENTAL
Intervention: C677T genotype
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: A1298C genotype
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Total homocysteine (HCY) levels
Number of subjects: 1023
Study: 35353553

Group type: EXPERIMENTAL
Intervention: Actionable alterations detected in tumors
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Treatment arm assignment
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Enrollment in treatment arms
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Prior clinical molecular testing history
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Actionable alterations in the mitogen-activated protein kinase signaling pathway
Number of subjects: 1000
Study: 34310692

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg·kg-1
Number of subjects: 78

Group type: COMPARATOR
Intervention: Remifentanil 2 µg·kg-1
Number of subjects: 78
Study: 32169459

Group type: EXPERIMENTAL
Intervention: Aquatic Cycling (AC) group, n=55, 45 min sessions, 2 times per week for 12 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual Care (UC) group, n=47
Number of subjects: 111
Study: 35313351

Group type: EXPERIMENTAL
Intervention: Auditory naming-related high gamma augmentation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Picture naming-related high gamma augmentation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Naming-related low gamma augmentation and alpha/beta attenuation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Auditory naming-based model
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Virtual resection of an electrical stimulation mapping-defined language site
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Virtual resection of an electrical stimulation mapping-defined receptive language site
Number of subjects: 65
Study: 34433897

Group type: EXPERIMENTAL
Intervention: Bacillus pumilus inoculated seeds at 0.25 mg kg‐1 of CdSO4
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bacillus pumilus uninoculated seeds at 0.75 mg kg‐1 of CdSO4
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (uninoculated seeds with no Cd)
Number of subjects: 0
Study: 35733400

Group type: EXPERIMENTAL
Intervention: PLUM risk calculator (RC)
Number of subjects: 1010

Group type: COMPARATOR
Intervention: PBCG risk calculator (RC)
Number of subjects: 1010
Study: 33315046

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Headache education
Number of subjects: 89
Study: 35594778

Group type: EXPERIMENTAL
Intervention: e‐CBT‐I (internet-delivered cognitive-behavioral therapy for insomnia)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group (initial control group had access to e‐CBT‐I)
Number of subjects: 255
Study: 34766929

Group type: EXPERIMENTAL
Intervention: Auricular seed acupressure
Number of subjects: 117

Group type: COMPARATOR
Intervention: Auricular acupuncture
Number of subjects: 117

Group type: COMPARATOR
Intervention: Auricular massage
Number of subjects: 117
Study: 33040826

Group type: EXPERIMENTAL
Intervention: LPS group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LPS + pcDNA group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35311633

Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes with produce allocations (PAE, n 39)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes only (EO, n 36)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n 45)
Number of subjects: 120
Study: 33532995

Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg·kg−1 bolus before surgery, followed by 0.05 mg·kg−1·hr−1 infusion until end of surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 100
Study: 32100388

Group type: EXPERIMENTAL
Intervention: Exercising >4 hr before bedtime
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Exercising with daylight exposure
Number of subjects: 43
Study: 35270624

Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT) 500 mg, three caplets
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA), three gelatin capsules
Number of subjects: 11

Group type: COMPARATOR
Intervention: Baseline (BSL), nothing ingested
Number of subjects: 11
Study: 34945073

Group type: EXPERIMENTAL
Intervention: Imiquimod
Number of subjects: 104

Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Imiquimod (CIN2p16+ subgroup)
Number of subjects: 104

Group type: COMPARATOR
Intervention: LLETZ (CIN2p16+ subgroup)
Number of subjects: 104
Study: 34686632

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Gait Training (RAGT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional Gait Training
Number of subjects: 37
Study: 36401407

Group type: EXPERIMENTAL
Intervention: Sopoongsan (treatment group, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (control group, n = 10)
Number of subjects: 20
Study: 34102012

Group type: EXPERIMENTAL
Intervention: Telehealth services (telephone or videoconference)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Telehealth services
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Telephone services
Number of subjects: 147
Study: 32877450

Group type: EXPERIMENTAL
Intervention: Native pop songs (NAT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: International pop songs (INT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Age-specific songs (20 randomly selected)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Experimental design
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Analysis of relationships between memory types and selected variables
Number of subjects: 65
Study: 35467095

Group type: EXPERIMENTAL
Intervention: Docetaxel treatment in mCRPC patients
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Docetaxel treatment in mHSPC patients
Number of subjects: 19
Study: 34400961

Group type: EXPERIMENTAL
Intervention: Olanzapine (0.14 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (matched to olanzapine)
Number of subjects: 40
Study: 36356214

Group type: EXPERIMENTAL
Intervention: Oxinium modular head with Spectron EF CoCrMo stem
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: CoCrMo modular head with Spectron EF CoCrMo stem
Number of subjects: 150

Group type: COMPARATOR
Intervention: Charnley monoblock stainless steel stem
Number of subjects: 150
Study: 33690687

Group type: EXPERIMENTAL
Intervention: Extreme gradient boosting
Number of subjects: 16120

Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 16120
Study: 32036964

Group type: EXPERIMENTAL
Intervention: CUR (400 mg/kg curcumin)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: OTA + CUR (2 mg/kg OTA plus 400 mg/kg curcumin)
Number of subjects: 720

Group type: COMPARATOR
Intervention: OTA (2 mg/kg OTA)
Number of subjects: 720
Study: 35659763

Group type: EXPERIMENTAL
Intervention: Radiofrequency turbinate reduction followed by intranasal steroid and Antihistamine H-1 (AH-1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intranasal steroid and Antihistamine H-1 (AH-1)
Number of subjects: 32
Study: 33215307

Group type: EXPERIMENTAL
Intervention: Bicruciate-retaining total knee arthroplasty (BCR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cruciate-retaining total knee arthroplasty (CR)
Number of subjects: 48
Study: 36254038

Group type: EXPERIMENTAL
Intervention: CTR with ultrasound guidance (CTR‐US)
Number of subjects: 120

Group type: COMPARATOR
Intervention: mini‐open CTR (mOCTR)
Number of subjects: 120
Study: 34217906

Group type: EXPERIMENTAL
Intervention: 25-hydroxyvitamin D3 (25OHD3)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Commercial diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: Diluent (control)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: D3
Number of subjects: 72

Group type: COMPARATOR
Intervention: ReCaP diet
Number of subjects: 72
Study: 32769261

Group type: EXPERIMENTAL
Intervention: Nomogram model based on multivariable regression analysis including 5 risk factors.
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Nomogram score for predicting multidrug-resistant bacterial infection risk.
Number of subjects: 121
Study: 35241426

Group type: EXPERIMENTAL
Intervention: deucravacitinib 6 mg once a day
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: deucravacitinib 12 mg once a day
Number of subjects: 203

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 203
Study: 33051119

Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting category of surgery
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting laterality of surgery
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting constraint type
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting presence of patellar resurfacing
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting implant model
Number of subjects: 20000
Study: 36709485

Group type: EXPERIMENTAL
Intervention: Provisional strategy
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: All strategies
Number of subjects: 438
Study: 33879820

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE), 40 min, cycle ergometer, 60% HRR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE), 40 min, 4×12 lower limb repetitions, 60% 1-RM
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined Exercise (CE), 20-min RE + 20-min AE
Number of subjects: 33
Study: 35427456

Group type: EXPERIMENTAL
Intervention: Koru Mindfulness intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 111
Study: 33750285

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 32811464

Group type: EXPERIMENTAL
Intervention: Dance Group (DG) - Brazilian dance program inspired by Samba and Forró rhythms, 24 sessions of 1 hour each, twice per week for 12 weeks.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Walking Group (WG) - Walking program, same duration and frequency as DG.
Number of subjects: 18
Study: 35763398

Group type: EXPERIMENTAL
Intervention: Socket shield technique with immediate implant placement in contact (Group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Socket shield technique with immediate implant placement leaving a gap (Group B)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study: 34511058

Group type: EXPERIMENTAL
Intervention: EKIT tool (digital medical decision aid)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 1080
Study: 36332653

Group type: COMPARATOR
Intervention: Combination prevention intervention with universal antiretroviral therapy (ART; arm A)
Number of subjects: 20422

Group type: COMPARATOR
Intervention: Prevention intervention with ART provided according to local guidelines (arm B)
Number of subjects: 20422

Group type: EXPERIMENTAL
Intervention: Standard of care (arm C)
Number of subjects: 20422
Study: 34921201

Group type: EXPERIMENTAL
Intervention: Computer-aided self-regulation learning (CA-SRL)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Traditional learning (TL)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Demonstration learning (DL)
Number of subjects: 72
Study: 32597621

Group type: EXPERIMENTAL
Intervention: Cooling suit recovery group
Number of subjects: 11
Study: 36438688

Group type: EXPERIMENTAL
Intervention: Camrelizumab (SHR‐1210) combined with gemcitabine plus cisplatin (GP) chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin (GP) chemotherapy
Number of subjects: 60
Study: 33248240

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (HbA1c target <6.0%)
Number of subjects: 9746

Group type: COMPARATOR
Intervention: Standard glycemic control (HbA1c target 7.0-7.9%)
Number of subjects: 9746

Group type: EXPERIMENTAL
Intervention: Abnormal 10 gm filament test
Number of subjects: 9746

Group type: EXPERIMENTAL
Intervention: Presence of ulceration
Number of subjects: 9746

Group type: EXPERIMENTAL
Intervention: Abnormal appearance on foot examination
Number of subjects: 9746

Group type: EXPERIMENTAL
Intervention: Mean postrandomization HbA1c
Number of subjects: 9746
Study: 33064609

Group type: EXPERIMENTAL
Intervention: 5% isoflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 18% desflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: isoflurane and sevoflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: desflurane
Number of subjects: 12
Study: 36212931

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (2 mg/kg bolus over 5 minutes, then 1.5 mg/kg/h infusion)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg over 5 minutes, followed by saline)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Saline (0.9% saline)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Lidocaine and Dexamethasone (compared to saline)
Number of subjects: 83
Study: 34103017

Group type: EXPERIMENTAL
Intervention: PREDICT intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study: 35999678

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (1 μg/kg) combined with oral midazolam (0.7 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral midazolam (0.7 mg/kg) alone
Number of subjects: 32
Study: 34380301

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD), physical exercises in the gym, daily walking up to 3-5 km/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low-calorie diet (LCD), physical exercises in the gym, daily walking up to 3-5 km/day, nutraceutical correction
Number of subjects: 120
Study: 35749413

Group type: EXPERIMENTAL
Intervention: 12-week Tai Chi program (45 minutes per session, twice a week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 40
Study: 33414036

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 69

Group type: COMPARATOR
Intervention: In-person
Number of subjects: 69
Study: 32255212

Group type: EXPERIMENTAL
Intervention: Custom-made 3D-printed drill guides
Number of subjects: 19

Group type: COMPARATOR
Intervention: Freehand insertion (control group)
Number of subjects: 19